ATRA vs DAL · rev $128.9M vs P/E 12, rev $61.64B
Atara Biotherapeutics Inc (ATRA) versus Delta Air Lines Inc (DAL) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Delta Air Lines Inc (DAL) is a airlines company listed on US. It is led by Ed Bastian.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported DAL revenue for 2024-12-31 was $61.64B. Net income was $3.46B. Revenue was up 6.2% from 2023-12-31 to 2024-12-31. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
ATRA currently screens at market cap $87.1M. DAL currently screens at market cap $52.18B and trailing P/E 11.6.
Not investment advice. Open the ATRA and DAL stock pages for the full models.
Not investment advice.